Nom du produit:3-Chloro-4-fluorobenzoic acid

IUPAC Name:3-chloro-4-fluorobenzoic acid

CAS:403-16-7
Formule moléculaire:C7H4ClFO2
Pureté:95%+
Numéro de catalogue:CM157718
Poids moléculaire:174.56

Unité d'emballage Stock disponible Prix($) Quantité
CM157718-100g in stock ŮŤ
CM157718-500g in stock ǸƴŮ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:403-16-7
Formule moléculaire:C7H4ClFO2
Point de fusion:-
Code SMILES:O=C(O)C1=CC=C(F)C(Cl)=C1
Densité:
Numéro de catalogue:CM157718
Poids moléculaire:174.56
Point d'ébullition:287.4°C at 760 mmHg
N° Mdl:MFCD00042477
Stockage:Store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

LEI-515
The recent publication titles “Structure–Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors”. Monoacylglycerol lipase (MAGL) is the critical enzyme responsible for the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG) to arachidonate and glycerol, contributing to the inflammatory cascade in the CNS. MAGL inhibition provides various potential therapeutic opportunities, including inflammation-induced tissue injury, pain, multiple sclerosis, and cancer.
LEI-515 is an aryl sulfoxide, and a peripherally restricted, covalent reversible MAGL inhibitor. LEI-515 increases 2-AG levels in the periphery and reduces neuropathic pain and inflammation, without inducing CNS adverse effects or physical dependence.